BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1452 related articles for article (PubMed ID: 10694087)

  • 1. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
    Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
    Mendoza MT; Gonzaga AJ; Roa C; Velmonte MA; Jorge M; Montoya JC; Tan Torres T; Ong M; Barez MY; Ang CF
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru.
    Timperi R; Han LL; Sloutsky A; Becerra MC; Nardell EA; Salazar JJ; Smith-Fawzi MC
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):175-80. PubMed ID: 15732737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.
    Churchyard GJ; Corbett EL; Kleinschmidt I; Mulder D; De Cock KM
    Int J Tuberc Lung Dis; 2000 May; 4(5):433-40. PubMed ID: 10815737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-resistant tuberculosis in Budapest.
    Fodor T; Vadász I; Lõrinczi I
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance among Mycobacterium tuberculosis isolates in Lebanon.
    Hamze MM; Araj GF
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):314-8. PubMed ID: 9432386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
    Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis.
    Abbadi SH; Sameaa GA; Morlock G; Cooksey RC
    Int J Infect Dis; 2009 Nov; 13(6):673-8. PubMed ID: 19138546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan.
    Javaid A; Hasan R; Zafar A; Ghafoor A; Pathan AJ; Rab A; Sadiq A; Akram CM; Burki I; Shah K; Ansari M; Rizvi N; Khan SU; Awan SR; Syed ZA; Iqbal ZH; Shaheen Z; ur Rehman N
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):326-31. PubMed ID: 18284840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
    Abate G; Miörner H; Ahmed O; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.